Screener
Arcus Biosciences RCUS Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Non-operating income (expense): | ||||
| Interest and other income, net | 8 | 10 | 17 | 21 |
| Interest expense | (3) | (2) | (6) | (3) |
| Total non-operating income, net | 5 | 8 | 11 | 18 |
| Income (loss) before income taxes | (91) | — | (219) | (112) |
| Income tax expense | — | — | — | — |
| Net income (loss) | $(91) | — | $(219) | $(112) |
| Net income (loss) per share: |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's other income (expense)?
- Arcus Biosciences (RCUS) reported other income (expense) of $5M in Q2 2026.
- How has Arcus Biosciences's other income (expense) changed year-over-year?
- Arcus Biosciences's other income (expense) decreased by 37.5% year-over-year, from $8M to $5M.
- What is the long-term trend for Arcus Biosciences's other income (expense)?
- Over 4 years (2021 to 2025), Arcus Biosciences's other income (expense) has grown at a 139.7% compound annual growth rate (CAGR), from $1M to $33M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Arcus Biosciences's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude